IL251040A0 - Use of cysteamine in treating infections caused by yeasts/moulds - Google Patents

Use of cysteamine in treating infections caused by yeasts/moulds

Info

Publication number
IL251040A0
IL251040A0 IL251040A IL25104017A IL251040A0 IL 251040 A0 IL251040 A0 IL 251040A0 IL 251040 A IL251040 A IL 251040A IL 25104017 A IL25104017 A IL 25104017A IL 251040 A0 IL251040 A0 IL 251040A0
Authority
IL
Israel
Prior art keywords
cysteamine
yeasts
moulds
infections caused
treating infections
Prior art date
Application number
IL251040A
Other languages
Hebrew (he)
Inventor
O'neil Deborah
DUNCAN Vanessa
Original Assignee
O'neil Deborah
DUNCAN Vanessa
Novabiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1416727.4A external-priority patent/GB201416727D0/en
Application filed by O'neil Deborah, DUNCAN Vanessa, Novabiotics Ltd filed Critical O'neil Deborah
Publication of IL251040A0 publication Critical patent/IL251040A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
IL251040A 2014-09-22 2017-03-08 Use of cysteamine in treating infections caused by yeasts/moulds IL251040A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462053523P 2014-09-22 2014-09-22
GBGB1416727.4A GB201416727D0 (en) 2014-09-22 2014-09-22 Use
PCT/GB2015/052714 WO2016046524A1 (en) 2014-09-22 2015-09-21 Use of cysteamine in treating infections caused by yeasts/moulds

Publications (1)

Publication Number Publication Date
IL251040A0 true IL251040A0 (en) 2017-04-30

Family

ID=54196996

Family Applications (1)

Application Number Title Priority Date Filing Date
IL251040A IL251040A0 (en) 2014-09-22 2017-03-08 Use of cysteamine in treating infections caused by yeasts/moulds

Country Status (1)

Country Link
IL (1) IL251040A0 (en)

Similar Documents

Publication Publication Date Title
IL283086A (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
HRP20192119T8 (en) Composition and method for aiding sleep
HUE047226T2 (en) Moulding body and method for its production
SG11201609652RA (en) Treatment of polybacterials infections
ZA201701330B (en) Use of cysteamine in treating infections caused by yeasts / moulds
SG11201702688UA (en) Methods of treating rsv infections
GB201416006D0 (en) Organotypic skin model
GB201416102D0 (en) Impovements In or Relating To Shower Rods
HK1225994A1 (en) Compositions for use in the treatment of allergic conditions
ZA201608607B (en) Novel fluoroquinolones and use thereof to treat bacterial infections
GB201405013D0 (en) Improvements in or relating to manufacture of packaging
IL249152A0 (en) Botulinum toxin for use in the treatment of paratonia
IL249616A0 (en) Methods for treating infections
IL251040A0 (en) Use of cysteamine in treating infections caused by yeasts/moulds
GB201709068D0 (en) Improvements in and relating to servo valves
PT3160263T (en) Compositions and methods for preventing infections
ZA201801788B (en) Lysobactin for use in the treatment of bovine mastitis
GB201521802D0 (en) Mould treatment
GB201410990D0 (en) General cure to diseases